These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4150063)

  • 1. Studies on group A (phage tail) bacteriocins of Serratia marcescens. I. Phenotypic variation of producer and indicator strains.
    Traub WH; Kleber I
    Zentralbl Bakteriol Orig A; 1973 Dec; 225(2):296-304. PubMed ID: 4150063
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on group A (phage tail) bacteriocins of Serratia marcescens. VI. Calcium ion-dependent biological activity of subgroup II bacteriocins.
    Traub WH; Kleber I
    Zentralbl Bakteriol Orig A; 1976 May; 234(4):528-35. PubMed ID: 779358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intracellular organisation of bacteriophage tail-like bacteriocins of group A in Serratia marcescens (author's transl)].
    Acker G
    Arch Microbiol; 1976 Dec; 111(1-2):175-83. PubMed ID: 797334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of group A bacteriocins of Serratia marcescens by nalidixic acid.
    Traub WH; Kleber I; Schaber I
    Nat New Biol; 1973 Oct; 245(144):144-5. PubMed ID: 4582895
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on group A (phage tail) bacteriocins of Serratia marcescens. V. Serological characterization of subgroup I and II bacteriocins.
    Traub WH; Kleber I
    Zentralbl Bakteriol Orig A; 1976 May; 234(4):521-7. PubMed ID: 779357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological differentiation of Serratia marcescens: typing by bacteriocin production.
    Farmer JJ
    Appl Microbiol; 1972 Feb; 23(2):218-25. PubMed ID: 4552884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteriocin (Marcescin) typing of clinical isolates of Serratia marcescens.
    Traub WH; Raymond EA; Startsman TS
    Appl Microbiol; 1971 May; 21(5):837-40. PubMed ID: 4930037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic variations of bacteriocin susceptibility, O-antigen determinants, and serum susceptibility among isolates of a multiple-drug-resistant, nosocomially significant strain of Serratia marcescens.
    Traub WH
    Zentralbl Bakteriol Orig A; 1978 Jan; 240(1):57-75. PubMed ID: 76383
    [No Abstract]   [Full Text] [Related]  

  • 9. Agar electrophoresis of antibiotics produced by Serratia marcescens.
    Prinsloo HE; Maré IJ; Coetzee JN
    Nature; 1965 Jun; 206(988):1055. PubMed ID: 5320268
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of nalidixic acid, rifampicin and chloramphenicol on the mitomycin C--induced synthesis of a bacteriocin of Serratia marcescens.
    Eichenlaub R; Winkler U
    Biochem Biophys Res Commun; 1974 Jul; 59(1):133-9. PubMed ID: 4601812
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of induction of group A bacteriocins of Serratia marcescens by rifampin.
    Traub WH
    Experientia; 1972 Aug; 28(8):986-8. PubMed ID: 4561798
    [No Abstract]   [Full Text] [Related]  

  • 12. Production of a bacteriophage, a phage tail-like bacteriocin and an antibiotic by Bacillus azotofixans.
    Seldin L; Penido EG
    An Acad Bras Cienc; 1990 Mar; 62(1):85-94. PubMed ID: 2129100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological differentiation of Serratia marcescens: typing by bacteriocin sensitivity.
    Farmer JJ
    Appl Microbiol; 1972 Feb; 23(2):226-31. PubMed ID: 4552885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and mode of action of two bacteriocins produced by Serratia marcesens HY.
    Eichenlaub R; Winkler U
    J Gen Microbiol; 1974 Jul; 83(0):83-94. PubMed ID: 4606968
    [No Abstract]   [Full Text] [Related]  

  • 15. Biosynthesis of the tripyrrole bacterial pigment, prodigiosin, by nonproliferating cells of Serratia marcescens.
    Hussain Qadri SM; Williams RP
    Tex Rep Biol Med; 1972; 30(1):73-83. PubMed ID: 4556681
    [No Abstract]   [Full Text] [Related]  

  • 16. Bacteriocin (marcescin) typing of clinically isolated Serratia marcescens.
    Nasu M
    Tohoku J Exp Med; 1981 Jan; 133(1):33-43. PubMed ID: 7015560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bacteriocins of Enterobacter liquefaciens. Taxonomic interest of their study].
    Hamon Y; Le Minor L; Peron Y
    C R Acad Hebd Seances Acad Sci D; 1970 Feb; 270(6):886-9. PubMed ID: 4984959
    [No Abstract]   [Full Text] [Related]  

  • 18. Bacteriocins and phages produced by Serratia marcescens.
    Prinsloo HE
    J Gen Microbiol; 1966 Nov; 45(2):205-12. PubMed ID: 5339480
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on group A (phage tail) bacteriocins of Serratia marcescens. III. Inhibition of beta-galactosidase activity (ONPG-hydrolysis) in sensitive indicator cells.
    Traub WH; Kleber I
    Zentralbl Bakteriol Orig A; 1974 Dec; 229(4):482-9. PubMed ID: 4155900
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on group A (phage tail) bacteriocins of Serratia marcescens. IV. Preliminary characterization of receptors of subgroup II bacteriocins.
    Traub WH; Kleber I
    Zentralbl Bakteriol Orig A; 1974 Dec; 229(4):490-502. PubMed ID: 4155901
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.